The Asia Pacific region is poised for substantial growth in the onychomycosis treatment market, with an anticipated annual increase of 9.3% from 2022 to 2031. This report delves into the factors ...

The Onychomycosis Treatment Market in Europe has witnessed substantial growth in recent years, with a valuation of Onychomycosis Treatment Market. Projections suggest a steady upward trajectory, ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Cutaneous fungal infections that generally require systemic antifungal therapy include tinea capitis and onychomycosis. Tinea capitis, which is most often caused by Trichophyton tonsurans ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...